These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3339611)

  • 1. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres.
    Wichrowski B; Jouquey S; Broquet C; Heymans F; Godfroid JJ; Fichelle J; Worcel M
    J Med Chem; 1988 Feb; 31(2):410-5. PubMed ID: 3339611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
    Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
    Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of 48740 R.P., a PAF-acether antagonist.
    Lefort J; Sedivy P; Desquand S; Randon J; Coëffier E; Maridonneau-Parini I; Floch A; Benveniste J; Vargaftig BB
    Eur J Pharmacol; 1988 Jun; 150(3):257-68. PubMed ID: 2843382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
    Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
    Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor.
    Grue-Sørensen G; Nielsen IM; Nielsen CK
    J Med Chem; 1988 Jun; 31(6):1174-8. PubMed ID: 3373485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
    Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
    J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity.
    Godfroid JJ; Broquet C; Jouquey S; Lebbar M; Heymans F; Redeuilh C; Steiner E; Michel E; Coeffier E; Fichelle J
    J Med Chem; 1987 May; 30(5):792-7. PubMed ID: 3572968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions.
    Lefort J; Wal F; Chignard M; Medeiros MC; Vargaftig BB
    Agents Actions; 1982 Dec; 12(5-6):723-5. PubMed ID: 7164948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
    Chignard M; Wal F; Lefort J; Vargaftig BB
    Eur J Pharmacol; 1982 Feb; 78(1):71-9. PubMed ID: 6804248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
    Pretolani M; Lefort J; Malanchère E; Vargaftig BB
    Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
    Achterrath-Tuckermann U; Weischer CH; Szelenyi I
    Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
    Touvay C; Etienne A; Braquet P
    Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
    Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
    Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.
    Tsuri T; Haga N; Matsui T; Kamata S; Kakushi H; Uchida K
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):75-84. PubMed ID: 1605805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous injections of PAF-acether induce platelet aggregation in rats.
    Martins MA; Martins PM; Faria Neto HC; Bozza PT; Dias PM; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1988 Apr; 149(1-2):89-96. PubMed ID: 3135199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.
    Lellouch-Tubiana A; Lefort J; Pirotzky E; Vargaftig BB; Pfister A
    Br J Exp Pathol; 1985 Jun; 66(3):345-55. PubMed ID: 3890915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of platelet activating factor (PAF) antagonists. II. Modification of the 2-position of the glycerol backbone of PAF-sulfonamide isosteres.
    Tsuri T; Matsui T; Haga N; Kamata S; Hagishita S; Takahashi K; Kakushi H; Uchida K; Hatakeyama H; Kurosawa A
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):85-95. PubMed ID: 1576692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.